The 7investing Podcast

The Science of Hitting (TSOH) moonlights as an investment columnist for GuruFocus where he has now penned more than 700 articles over the past nine years. While doing so he has also built up a loyal following on Twitter where he can be found dishing out investment quotes and thoughtful takes on the market and stocks. In an exclusive interview, TSOH sat down with 7investing lead advisor Matthew Cochrane to discuss his investment style, process, and the bull theses for some of his largest positions.   Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

On this Wednesday edition of 7investing Now, Dan is joined by 7investing CEO Simon Erickson, and our newest Lead Advisor Manisha Samy to discuss their takes on the future of Pfizer and Boeing.  Plus, the team will answer some of our most asked questions from our followers on Twitter.    Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

There’s no doubt the pandemic has helped accelerate the growth story for iRobot (NASDAQ: IRBT). Best known for its Roomba robotic vacuums, iRobot’s revenue soared 43% year over year in the third quarter, buoyed by a 70% increase in e-commerce sales and an 86% jump in sales of its premium ($500 or above) robots.   But iRobot’s ambitions extend well beyond its flagship vacuum line. In this exclusive interview with 7investing Lead Advisor Steve Symington, iRobot Chairman, co-founder, and CEO Colin Angle covers everything from iRobot's efforts to build stronger direct relationships with consumers to the recent launch of their Genius Home Intelligence Platform, the challenges of tariffs and international trade tensions, the status of their Terra robotic lawnmower project, and the company’s longer-term vision for smart homes and the home-robotics industry.   Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

This morning, Dan Kline, Maxx Chatsko, Steve Symington, and Austin Lieberman as the team discusses how Moderna's 94% effective vaccine will impact the stock market. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

Airbnb, Roblox, WIsh, and DoorDash all plan to go public soon, so we'll take a look at their prospects. We'll also dig into Disney's earning and some news from Fastly. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

Normally, the American Customer Satisfaction Index (ACSI) does one extensive survey each year for every industry it covers. This year, as you almost certainly know, has not been a normal year. The pandemic has accelerated a number of trends and has caused some shorter-term changes to how people shop for a number of things including groceries. That led the ACSI to decide to do a second set of surveys this year covering retail, supermarkets, and internet retail. The results showed that things have changed for many companies in this space. It’s a case where some winners when it comes to dollars may not be doing a great job keeping customers happy. ACSI Managing Director David VanAmburg joined the 7investing podcast to help parse the results and to explain which companies have proven to be the winners and losers when it comes to customer satisfaction. That’s not always a clear answer, but the ACSI report shows that some of retail’s big winners may not be keeping their customers happy and that’s something investors should at least consider. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

The market has been volatile (to say the least). We explain why, and why you should tune it out. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

As we sit on the eve of Veteran’s Day, Dan Kline welcomes Hernán Luis y Prado, founder and CEO of Workshops for Warriors (WFW), Workshops for Warriors is a State-licensed, board governed, fully audited 501(c)(3) nonprofit school that trains, certifies, and helps place Veterans, Wounded Warriors, and Transitioning Service Members into advanced manufacturing careers. Students earn nationally recognized portable and stackable credentials. The program addresses two major needs. First, it helps fill open manufacturing jobs. These are positions that companies need to fill in order to manufacture within the United States. Second, Workshop for Warriors helps veterans find a successful career path after their military service ends. Why is this important for investors? There are expected to be 2.4 million open highly-skilled manufacturing jobs in the U.S. over the next decade. WFW has partnered with companies including Ford (NYSE:F) Qualcomm (NASDAQ: QCOM), Boeing (NYSE: BA), and many others to help train veterans to fill those rolls. This shortfall, however, is a bigger looming problem for American manufacturers than one non-profit can fill. Understanding what’s being done, where demand stands, and what still needs to be done may change how you view manufacturing and the changing job market -- two key areas for investors to focus on. A Navy veteran himself, Hernán understands how veterans can help solve this problem and why it’s important for the U.S. to build back its manufacturing capacity. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

On today's episode of 7investing Now, Dan Kline, Steve Symington, and Austin Lieberman discuss what Pfizer's new vaccine means for the stock market.    Pfizer nearing the finish line with its 90% effective vaccine comes something we are all looking forward to - an end to the pandemic and a return to normalcy.   Are there any companies though who will be hurt by pandemic coming to an end?  Tune in to hear the team's thoughts at 12 ET!    Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing

7investing Now's host, Dan Kline, is joined today by Matt Cochrane, Steve Symington, and Maxx Chatsko as the team discusses why the market is on fire even with all the uncertainty around the election. Welcome to 7investing. We are here to empower you to invest in your future! We publish our 7 best ideas in the stock market to our subscribers for just $49 per month or $399 per year. Start your journey toward's financial independence: https://www.7investing.com/subscribe Stop by our website to level-up your investing education:  https://www.7investing.com Follow us on Social Media ► https://www.facebook.com/7investing/ ► https://twitter.com/7investing ► https://instagram.com/7investing